UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.13 -2.80 (-3.42%) GOLD FUTURES
2,330.20 +27.30 (+1.19%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,202.61 -1,828.75 (-3.81%)
Sangamo Therapeutics, Inc. (SGMO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.5149 |
| Open | 0.5237 |
| Bid | 0.5379 x 500 |
| Ask | 0.5459 x 400 |
| Day's range | 0.5164 - 0.5739 |
| 52-week range | 0.2900 - 1.6700 |
| Volume | |
| Avg. volume | 2,425,932 |
| Market cap | 112.836M |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
RICHMOND, Calif., April 22, 2024--Sangamo Therapeutics to Present Neurology Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at ASGCT
- Business Wire
Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
RICHMOND, Calif., March 22, 2024--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING
- Business Wire
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
RICHMOND, Calif., March 13, 2024--Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
© 2024 Yahoo. All rights reserved.